Video: Knock on Wood| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Search results for: Gout

European Commission Approves Subcutaneous Belimumab for SLE; FDA Safety Alert for Febuxostat

Michele B. Kaufman, PharmD, BCGP  |  November 29, 2017

Subcutaneous belimumab has been approved in the EU to help treat patients with active autoantibody-positive SLE…

Filed under:ConditionsDrug UpdatesGout and Crystalline Arthritis Tagged with:belimumabcardiovascularEuropean UnionFebuxostatGoutInternationalsystemic lupus erythematosus (SLE)

Year in Review: Expert Covers 2017’s Key Clinical Findings

Thomas R. Collins  |  November 20, 2017

In a Year in Review session at the 2017 ACR/ARHP Annual Meeting, Daniel Solomon, MD, MPH, highlighted the latest and most intriguing aspects of clinical research on rheumatic diseases from 2017. His discussion touched on medical therapy, genetics, the effects of bariatric surgery and diet, cancer risk and more…

Filed under:Axial SpondyloarthritisConditionsGout and Crystalline ArthritisMeeting ReportsResearch Rheum Tagged with:2017 ACR/ARHP Annual MeetingACR/ARHP Annual MeetingAnkylosing SpondylitiscardiovascularDASH dietGoutjuvenile idiopathic arthritis (JIA)Knee Osteoarthritis (OA)secukinumab

How Non-Physician Providers Can Help Your Practice

Richard Quinn  |  November 17, 2017

New data shows that both private and public rheumatology practices benefit financially by hiring non-physician providers (NPPs). But when should practices hire NPPs?

Filed under:Practice SupportWorkforce Tagged with:Medical Group Management Associationnon-physician providerPractice Managementrheumatologystaffstaffing

Eat to Fight Inflammation & Promote Weight Loss

Karen Appold  |  November 11, 2017

Managing weight loss through diet may help patients with rheumatic disease reduce inflammation. Here are some strategies on weight loss and eating for rheumatologists and patients…

Filed under:ConditionsOther Rheumatic Conditions Tagged with:DieteatingfoodMediterranean dietweight loss

FDA Approves Lesinurad + Allopurinol

Michele B. Kaufman, PharmD, BCGP  |  September 19, 2017

Duzallo, a combination of lesinurad and allopurinol, was approved by the FDA in August to treat hyperuricemia associated with gout…

Filed under:ConditionsDrug UpdatesGout and Crystalline Arthritis Tagged with:AllopurinolDuzalloFDAFood and Drug AdministrationGouthyperuricemialesinuradU.S. Food and Drug Administration

Support Rheumatic Disease Awareness Month in September

Sharad Lakhanpal, MBBS, MD  |  September 18, 2017

Wider awareness and understanding of the more than 100 different rheumatic diseases is a vital element in our work as rheumatologists and rheumatology health professionals. Stimulating interest and engagement among lawmakers, patient groups and the public at large is essential to successful advocacy efforts, as well as the overall future of our specialty. This September,…

Filed under:Legislation & AdvocacyPresident's Perspective Tagged with:AC&RAdvocacyAmerican College of Rheumatology (ACR)AwarenesscampaignDiseaseRheumatic DiseaserheumatologySimple TasksTerry Bradshaw

Electronic Registers and Best Practices to Improve Patient Care in Rheumatic Disease

Thomas R. Collins  |  September 17, 2017

MADRID—Determining what is a best practice in rheumatology and then implementing improvements based on what you find can be fraught with complexity, an expert said during the 2017 Annual European Congress on Rheumatology (EULAR). Examples are emerging of benchmarking projects in which electronic registers are used to improve patient care, said William Dixon, MD, chair…

Filed under:ConditionsTechnology Tagged with:AC&RAmerican College of Rheumatology (ACR)Annual European Congress of Rheumatologybenchmarkingbest practiceselectronic health recordEULARpatient carepatient registryPractice ManagementrheumatologistRISE

How to Manage Pain & Treatment in Elderly Patients

Richard Quinn  |  August 25, 2017

Elderly patients have unique requirements with regard to treatment for pain, rheumatic disease and other ailments. Collaboration between rheumatologists, geriatricians and primary care physicians is essential to avoid unnecessary interventions and improve care for this patient population…

Filed under:Practice Support Tagged with:elderlygeriatricgeriatricspatient careTreatment

Opinion: Help Bring Drug Prices Down

Maarten Boers, MSc, MD, PhD  |  August 22, 2017

I read with interest the articles in the June issue of The Rheumatologist pertaining to high drug costs. Simon Helfgott rheuminated on it, and Susan Bernstein, a medical journalist, wrote a two-page article titled “Concerns About Cost.” Both articles were thoughtful summaries of a complex issue, putting large question marks over both initial prices and…

Filed under:Biologics/DMARDsOpinionSpeak Out Rheum Tagged with:Institute for Clinical and Economic Review (ICER)PATAPatient Access to Treatment Act

Registries & Benchmarking: Implementation of Best Practices Can Work—If Done Right

Thomas R. Collins  |  August 15, 2017

MADRID—Determining what is a best practice in rheumatology and then implementing improvements based on what you find can be fraught with complexity, an expert said during the 2017 Annual European Congress on Rheumatology (EULAR). Examples are emerging of benchmarking projects in which electronic registers are used to improve patient care, said William Dixon, MD, chair…

Filed under:Practice Support Tagged with:benchmark toolbest practicespatient care

  • « Previous Page
  • 1
  • …
  • 33
  • 34
  • 35
  • 36
  • 37
  • …
  • 59
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences